v3.24.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2023
Sep. 30, 2023
Current assets:    
Cash and cash equivalents $ 40,579,059 $ 9,625,494
Accounts receivable, net 2,382,937 4,506,508
Inventories, net 6,912,203 6,697,117
Prepaid research and development costs 1,228,509 1,006,252
Prepaid expenses and other current assets 2,241,959 1,097,851
Total current assets 53,344,667 22,933,222
Plant and equipment, net 1,560,325 1,652,732
Operating lease right-of-use assets 4,133,726 4,332,473
Investments in equity securities 538,474  
Deferred income taxes 12,788,705 12,707,419
Goodwill 6,878,932 6,878,932
Other assets 1,322,056 1,518,313
Total assets 80,566,885 50,023,091
Current liabilities:    
Accounts payable 10,518,382 12,931,172
Accrued compensation 2,153,893 990,609
Accrued expenses and other current liabilities 2,083,956 1,987,738
Residual royalty agreement liability, short-term portion 825,180 864,623
Operating lease liability, short-term portion 1,043,342 1,036,590
Total current liabilities 16,624,753 17,810,732
Residual royalty agreement liability, long-term portion 8,883,432 8,870,136
Operating lease liability, long-term portion 3,456,428 3,634,114
Other liabilities   29,948
Total liabilities 28,964,613 30,344,930
Commitments and contingencies (Note 12)
Stockholders' equity:    
Preferred stock; no shares issued and outstanding at December 31, 2023 and September 30, 2023
Common stock, par value $0.01 per share; 308,000,000 shares authorized, 148,564,890 and 93,966,402 shares issued and 146,381,186 and 91,782,698 shares outstanding at December 31, 2023 and September 30, 2023, respectively 1,485,649 939,664
Additional paid-in-capital 323,548,937 283,894,830
Accumulated other comprehensive loss (581,519) (581,519)
Accumulated deficit (265,044,190) (256,768,209)
Treasury stock, 2,183,704 shares, at cost (7,806,605) (7,806,605)
Total stockholders' equity 51,602,272 19,678,161
Total liabilities and stockholders' equity $ 80,566,885 $ 50,023,091

Source

PDF HTML
ZIP XLS HTML